ZMYM1
gene geneOn this page
Also known as FLJ23151MYM
Summary
ZMYM1 (zinc finger MYM-type containing 1, HGNC:26253) is a protein-coding gene on chromosome 1p34.3, encoding Zinc finger MYM-type protein 1 (Q5SVZ6).
Predicted to enable protein dimerization activity and zinc ion binding activity. Predicted to be located in nucleus.
Source: NCBI Gene 79830 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 139 total
- MANE Select transcript:
NM_024772
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26253 |
| Approved symbol | ZMYM1 |
| Name | zinc finger MYM-type containing 1 |
| Location | 1p34.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ23151, MYM |
| Ensembl gene | ENSG00000197056 |
| Ensembl biotype | protein_coding |
| Entrez | 79830 |
Gene structure
Transcript identifiers
Ensembl transcripts: 28 — 22 protein_coding, 6 protein_coding_CDS_not_defined
ENST00000359858, ENST00000373329, ENST00000373330, ENST00000417119, ENST00000463393, ENST00000466390, ENST00000475654, ENST00000476269, ENST00000488455, ENST00000611874, ENST00000650449, ENST00000905955, ENST00000905956, ENST00000905957, ENST00000905958, ENST00000931028, ENST00000931029, ENST00000931030, ENST00000931031, ENST00000931032, ENST00000931033, ENST00000931034, ENST00000931035, ENST00000931036, ENST00000964798, ENST00000964799, ENST00000964800, ENST00000964801
RefSeq mRNA: 6 — MANE Select: NM_024772
NM_001289088, NM_001289089, NM_001289090, NM_001289091, NM_001319955, NM_024772
CCDS: CCDS41302
Canonical transcript exons
ENST00000359858 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001460285 | 35112977 | 35115859 |
| ENSE00001460290 | 35079385 | 35079442 |
| ENSE00003477630 | 35093914 | 35094083 |
| ENSE00003498284 | 35097317 | 35097566 |
| ENSE00003535611 | 35095819 | 35095891 |
| ENSE00003697440 | 35110294 | 35110447 |
| ENSE00003698994 | 35104295 | 35104469 |
| ENSE00003699331 | 35112087 | 35112130 |
| ENSE00003700711 | 35111772 | 35111912 |
| ENSE00003701996 | 35104557 | 35104769 |
Expression profiles
Bgee: expression breadth ubiquitous, 231 present calls, max score 88.33.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.4533 / max 279.7789, expressed in 1758 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 2084 | 11.4533 | 1758 |
Top tissues by expression
269 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.33 | gold quality |
| adrenal tissue | UBERON:0018303 | 87.72 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.17 | gold quality |
| calcaneal tendon | UBERON:0003701 | 85.78 | gold quality |
| ventricular zone | UBERON:0003053 | 83.23 | gold quality |
| stromal cell of endometrium | CL:0002255 | 80.59 | gold quality |
| ganglionic eminence | UBERON:0004023 | 79.54 | gold quality |
| cortical plate | UBERON:0005343 | 78.96 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 78.45 | gold quality |
| islet of Langerhans | UBERON:0000006 | 78.15 | gold quality |
| visceral pleura | UBERON:0002401 | 77.89 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 77.86 | gold quality |
| monocyte | CL:0000576 | 77.80 | gold quality |
| right ovary | UBERON:0002118 | 77.77 | gold quality |
| mononuclear cell | CL:0000842 | 77.65 | gold quality |
| hair follicle | UBERON:0002073 | 77.65 | silver quality |
| leukocyte | CL:0000738 | 77.59 | gold quality |
| tibia | UBERON:0000979 | 77.46 | gold quality |
| parietal pleura | UBERON:0002400 | 77.46 | gold quality |
| rectum | UBERON:0001052 | 77.40 | gold quality |
| ovary | UBERON:0000992 | 77.21 | gold quality |
| endometrium | UBERON:0001295 | 77.16 | gold quality |
| left ovary | UBERON:0002119 | 77.16 | gold quality |
| gingival epithelium | UBERON:0001949 | 77.12 | silver quality |
| ectocervix | UBERON:0012249 | 76.89 | gold quality |
| pleura | UBERON:0000977 | 76.84 | gold quality |
| tonsil | UBERON:0002372 | 76.78 | gold quality |
| body of uterus | UBERON:0009853 | 76.67 | gold quality |
| esophagus mucosa | UBERON:0002469 | 76.36 | gold quality |
| right uterine tube | UBERON:0001302 | 76.31 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-99795 | no | 119.07 |
| E-ANND-3 | no | 5.60 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
57 targeting ZMYM1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6748-5P | 100.00 | 65.81 | 1057 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-520G-5P | 99.99 | 66.76 | 658 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-485-3P | 99.98 | 70.68 | 1585 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-141-3P | 99.94 | 72.79 | 2421 |
| HSA-MIR-200A-3P | 99.94 | 72.68 | 2420 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-7856-5P | 99.75 | 69.99 | 2901 |
| HSA-MIR-1208 | 99.70 | 68.28 | 1533 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:ch211-240b21.2 | ENSDARG00000068279 |
| mus_musculus | Zmym1 | ENSMUSG00000043872 |
| rattus_norvegicus | Zmym1 | ENSRNOG00000013855 |
Paralogs (18): GTF2IRD1 (ENSG00000006704), ZMYM2 (ENSG00000121741), ZMYM5 (ENSG00000132950), THAP12 (ENSG00000137492), ZMYM4 (ENSG00000146463), ZMYM3 (ENSG00000147130), ZMYM6 (ENSG00000163867), KIAA1958 (ENSG00000165185), GTF2IRD2B (ENSG00000174428), EPM2AIP1 (ENSG00000178567), GTF2IRD2 (ENSG00000196275), QRICH1 (ENSG00000198218), FAM200C (ENSG00000221886), FAM200A (ENSG00000221909), SCAND3 (ENSG00000232040), ZBED5 (ENSG00000236287), FAM200B (ENSG00000237765), GTF2I (ENSG00000263001)
Protein
Protein identifiers
Zinc finger MYM-type protein 1 — Q5SVZ6 (reviewed: Q5SVZ6)
All UniProt accessions (2): Q5SVZ6, Q5SVZ7
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
RefSeq proteins (6): NP_001276017, NP_001276018, NP_001276019, NP_001276020, NP_001306884, NP_079048* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008906 | HATC_C_dom | Domain |
| IPR010507 | Znf_MYM | Domain |
| IPR011017 | TRASH_dom | Domain |
| IPR012337 | RNaseH-like_sf | Homologous_superfamily |
| IPR025398 | RNase-like_ZMYM1 | Domain |
| IPR051284 | ZnF_MYMT-QRICH1 | Family |
Pfam: PF05699, PF06467, PF14291, PF24900
UniProt features (14 total): zinc finger region 5, sequence variant 3, cross-link 2, compositionally biased region 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5SVZ6-F1 | 67.23 | 0.19 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 284, 25
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 87 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN, MODULE_285, FISCHER_G2_M_CELL_CYCLE, chr1p34, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, FISCHER_DREAM_TARGETS, YAMAZAKI_TCEB3_TARGETS_DN, MARSON_BOUND_BY_E2F4_UNSTIMULATED, KIM_WT1_TARGETS_DN, GOMF_PROTEIN_DIMERIZATION_ACTIVITY, BOCHKIS_FOXA2_TARGETS, GEORGES_TARGETS_OF_MIR192_AND_MIR215, HAMAI_APOPTOSIS_VIA_TRAIL_UP, WHITFIELD_CELL_CYCLE_G2_M, HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP
GO Biological Process (0):
GO Molecular Function (3): zinc ion binding (GO:0008270), protein dimerization activity (GO:0046983), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transition metal ion binding | 1 |
| protein binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
822 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZMYM1 | RCOR1 | Q9UKL0 | 593 |
| ZMYM1 | ELAVL1 | Q15717 | 578 |
| ZMYM1 | CTBP1 | Q13363 | 576 |
| ZMYM1 | METTL3 | Q86U44 | 570 |
| ZMYM1 | KDM1A | O60341 | 549 |
| ZMYM1 | METTL14 | Q9HCE5 | 448 |
| ZMYM1 | HDGF | P51858 | 447 |
| ZMYM1 | WTAP | Q15007 | 434 |
| ZMYM1 | YTHDF1 | Q9BYJ9 | 431 |
| ZMYM1 | ALKBH5 | Q6P6C2 | 420 |
| ZMYM1 | VIRMA | Q69YN4 | 400 |
| ZMYM1 | YTHDF2 | Q9Y5A9 | 398 |
| ZMYM1 | TMEM35B | Q8NCS4 | 396 |
| ZMYM1 | RBM15 | Q96T37 | 384 |
| ZMYM1 | IGF2BP2 | Q9Y6M1 | 373 |
IntAct
84 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RNF146 | TNKS | psi-mi:“MI:0914”(association) | 0.790 |
| CAMK2A | CAMK2G | psi-mi:“MI:0914”(association) | 0.730 |
| GPR156 | PLD2 | psi-mi:“MI:0914”(association) | 0.640 |
| ERP44 | MEX3A | psi-mi:“MI:0914”(association) | 0.530 |
| TRIM44 | ODAD3 | psi-mi:“MI:0914”(association) | 0.530 |
| PSG9 | CCDC85C | psi-mi:“MI:0914”(association) | 0.530 |
| XAGE1A | THAP12 | psi-mi:“MI:0914”(association) | 0.530 |
| SALL2 | GFPT2 | psi-mi:“MI:0914”(association) | 0.530 |
| FHL5 | ZMYM6 | psi-mi:“MI:0914”(association) | 0.530 |
| ELP2 | DNAJA2 | psi-mi:“MI:0914”(association) | 0.530 |
| USP7 | ZMYM1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| Ctcf | RPL36A | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZMYM1 | ABLIM1 | psi-mi:“MI:0914”(association) | 0.350 |
| SKA1 | ILVBL | psi-mi:“MI:0914”(association) | 0.350 |
| AURKA | CTNNB1 | psi-mi:“MI:0914”(association) | 0.350 |
| Ttll12 | TPM1 | psi-mi:“MI:0914”(association) | 0.350 |
| L1TD1 | PPP1R12C | psi-mi:“MI:0914”(association) | 0.350 |
| Prdx1 | TRIO | psi-mi:“MI:0914”(association) | 0.350 |
| Chmp3 | DTL | psi-mi:“MI:0914”(association) | 0.350 |
| RNASEH2B | SAP18 | psi-mi:“MI:0914”(association) | 0.350 |
| Chmp4c | SF1 | psi-mi:“MI:0914”(association) | 0.350 |
| HDAC6 | GLOD5 | psi-mi:“MI:0914”(association) | 0.350 |
| GAR1 | TAF1 | psi-mi:“MI:0914”(association) | 0.350 |
| VAPA | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (107): ZMYM1 (Affinity Capture-MS), ZMYM1 (Affinity Capture-MS), ZMYM1 (Affinity Capture-MS), ZMYM1 (Affinity Capture-MS), ZMYM1 (Affinity Capture-MS), ZMYM1 (Affinity Capture-MS), ZMYM1 (Affinity Capture-MS), ZMYM1 (Affinity Capture-MS), ZMYM1 (Affinity Capture-MS), ZMYM1 (Affinity Capture-MS), ZMYM1 (Affinity Capture-MS), ZMYM1 (Affinity Capture-MS), ZMYM1 (Affinity Capture-MS), ZMYM1 (Affinity Capture-MS), ZMYM1 (Affinity Capture-MS)
ESM2 similar proteins: A3KMX0, A4IFA3, A4IGY9, A4Z943, A4Z944, B8QB46, D2EAC2, E1C2V1, O43422, O60290, P10911, P35125, P86452, Q13075, Q2NKX8, Q3UPF5, Q49AG3, Q5FWF4, Q5SVZ6, Q5T890, Q5TKR9, Q6DJS0, Q6EKJ0, Q6R2W3, Q6YI93, Q7Z2W4, Q80WE4, Q86UP8, Q86VD1, Q8BZ21, Q8N8K9, Q8QMP8, Q8TDB6, Q8WML3, Q92794, Q96JM7, Q96JS3, Q99388, Q99NI3, Q9CUX1
Diamond homologs: A2A791, A6QPH9, O95789, Q0P5J0, Q14202, Q2TAL8, Q3U2E2, Q3UA37, Q4R3D6, Q5RDJ2, Q5SVZ6, Q5VZL5, Q9CU65, Q9JLM4, Q9UBW7, Q9UJ78, A4Z943, A4Z944, A4Z945, P0CF97, Q49AG3, Q4R6P1, Q6R2W3, Q8IZ13, Q8TCP9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
139 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 118 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1918 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:35094084:G:GG | donor_gain | 1.0000 |
| 1:35104293:A:AG | acceptor_gain | 1.0000 |
| 1:35104294:G:GG | acceptor_gain | 1.0000 |
| 1:35104294:GA:G | acceptor_gain | 1.0000 |
| 1:35104294:GAGAC:G | acceptor_gain | 1.0000 |
| 1:35104470:G:GG | donor_gain | 1.0000 |
| 1:35110290:ACAG:A | acceptor_loss | 1.0000 |
| 1:35110291:CA:C | acceptor_loss | 1.0000 |
| 1:35110292:A:AC | acceptor_loss | 1.0000 |
| 1:35110292:A:AG | acceptor_gain | 1.0000 |
| 1:35110293:G:GA | acceptor_gain | 1.0000 |
| 1:35110327:A:AG | acceptor_gain | 1.0000 |
| 1:35110328:A:G | acceptor_gain | 1.0000 |
| 1:35110427:C:G | donor_gain | 1.0000 |
| 1:35110443:TTCAG:T | donor_loss | 1.0000 |
| 1:35110444:TCAG:T | donor_loss | 1.0000 |
| 1:35110445:CAGG:C | donor_loss | 1.0000 |
| 1:35110446:AGGTA:A | donor_loss | 1.0000 |
| 1:35110447:GG:G | donor_loss | 1.0000 |
| 1:35110448:GTA:G | donor_loss | 1.0000 |
| 1:35110449:T:G | donor_loss | 1.0000 |
| 1:35111771:GTA:G | acceptor_gain | 1.0000 |
| 1:35111771:GTAA:G | acceptor_gain | 1.0000 |
| 1:35111908:ACAAG:A | donor_loss | 1.0000 |
| 1:35111909:CAAG:C | donor_loss | 1.0000 |
| 1:35111910:AAG:A | donor_loss | 1.0000 |
| 1:35111912:G:GC | donor_loss | 1.0000 |
| 1:35111913:GTAA:G | donor_loss | 1.0000 |
| 1:35111914:T:G | donor_loss | 1.0000 |
| 1:35112085:A:AG | acceptor_gain | 1.0000 |
AlphaMissense
7584 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:35114910:T:C | L1027P | 0.991 |
| 1:35097412:T:C | C89R | 0.986 |
| 1:35113610:G:C | A594P | 0.986 |
| 1:35097481:T:C | F112L | 0.985 |
| 1:35097483:C:A | F112L | 0.985 |
| 1:35097483:C:G | F112L | 0.985 |
| 1:35097414:T:G | C89W | 0.984 |
| 1:35097550:T:C | C135R | 0.984 |
| 1:35097552:T:G | C135W | 0.984 |
| 1:35097412:T:A | C89S | 0.983 |
| 1:35097413:G:C | C89S | 0.983 |
| 1:35104374:T:C | C167R | 0.982 |
| 1:35097421:T:A | C92S | 0.981 |
| 1:35097422:G:C | C92S | 0.981 |
| 1:35104376:T:G | C167W | 0.980 |
| 1:35114918:T:G | Y1030D | 0.980 |
| 1:35097484:T:C | C113R | 0.979 |
| 1:35097550:T:A | C135S | 0.979 |
| 1:35097551:G:C | C135S | 0.979 |
| 1:35097413:G:A | C89Y | 0.976 |
| 1:35097484:T:A | C113S | 0.976 |
| 1:35097485:G:C | C113S | 0.976 |
| 1:35097496:T:C | C117R | 0.976 |
| 1:35114831:T:A | W1001R | 0.975 |
| 1:35114831:T:C | W1001R | 0.975 |
| 1:35114922:G:C | R1031P | 0.975 |
| 1:35114741:G:A | G971R | 0.973 |
| 1:35114741:G:C | G971R | 0.973 |
| 1:35097486:C:G | C113W | 0.972 |
| 1:35097561:C:G | C138W | 0.972 |
dbSNP variants (sampled 300 via entrez): RS1000032360 (1:35064906 A>G), RS1000063030 (1:35080283 C>T), RS1000122302 (1:35087301 T>A), RS1000158729 (1:35084036 A>G), RS1000175368 (1:35105371 T>C), RS1000191077 (1:35101637 G>A), RS1000307518 (1:35076709 G>T), RS1000332236 (1:35092658 C>T), RS1000336139 (1:35099516 T>C), RS1000584865 (1:35108622 G>A), RS1000594392 (1:35082198 G>C,T), RS1000639807 (1:35064100 T>C,G), RS1000701272 (1:35118798 A>G), RS1000701457 (1:35061508 G>A), RS1000711363 (1:35077034 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004751_3 | Serum uric acid levels in response to allopurinol in gout | 4.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004761 | uric acid measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
26 total (human), top 26 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | decreases expression, affects expression, increases abundance | 2 |
| TAK-243 | increases sumoylation | 1 |
| bufotalin | increases expression | 1 |
| testosterone enanthate | affects expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| arsenite | affects binding, decreases reaction | 1 |
| mono-(2-ethylhexyl)phthalate | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| manganese chloride | increases abundance, increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| jinfukang | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cisplatin | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Manganese | increases abundance, increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Testosterone | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.